Share This Author
Preferences for oral and parenteral antitumor therapy: A survey of 260 patients with metastatic breast cancer
This study evaluated preferences for oral chemotherapy (OC) vs IV chemotherapy (IC) and oral (OE) vs IM endocrine therapy (IME) and found that oral therapy is preferable, because of the perceived inconvenience and discomfort of parenteral therapy (PT). Expand
Influence of prior therapy on breast cancer survivors' preferences for adjuvant systemic therapy in hypothetical scenarios.
- N. Love, P. Ravdin, G. Hortobagyi, G. Grana, M. Paley, L. Poltorack
- Journal of clinical oncology : official journal…
- 15 July 2004
Breast cancer survivors who had received prior C or T had different perspectives on AST decisions than those who had not received prior therapy, and those who did not were more likely to choose adjuvant A than T. Expand